Rockwell Medical Announces Third Quarter 2026 Results

Rockwell Medical reported third-quarter 2026 net sales of $19.1 million, up 20% year over year, while gross profit increased 37%, primarily due to higher product volumes. The company said demand and disciplined execution supported its momentum. Its planned combination with Vantive’s global hemodialysis business is projected to generate $400 million to $450 million in annual revenue.